Glutathione-S-Transferase M1 and T1 Null Genotypes Are Associated with Hypertension Risk: A Systematic Review and Meta-Analysis of 12 Studies
- 348 Downloads
Oxidative stress is known to be implicated in the pathogenesis of essential hypertension. Glutathione-S-transferase (GST) enzymes are key components of cellular defense against oxidative stress. The present study aimed to clarify the association between polymorphisms in GST and risk of essential hypertension using a meta-analysis of published studies. PubMed-Medline, Ovid-EMBASE, HuGE Navigator and SCOPUS databases were searched to identify case-control studies that examined the association of GST polymorphisms and hypertension. Data were extracted using standardized methods. Combined odds ratios (OR) with 95 % confidence intervals (CI) for the association of polymorphisms with hypertension were calculated using a fixed effect approach and under dominant, recessive, additive and overdominant models of inheritance. A total of 12 studies comprising 2,040 cases and 2,462 controls fulfilled the inclusion criteria. GSTM1 (presence/null), GSTT1 (presence/null) and GSTP1 (Ile105Val; rs1695) polymorphisms were evaluated. Meta-analysis revealed significant associations between the null genotypes of GSTM1 (OR: 1.22; 95 % CI: 1.08–1.39; p = 0.002) and GSTT1 (OR: 1.30; 95 % CI: 1.13–1.50; p = 0.0003) and risk of hypertension. The observed associations were robust in sensitivity analyses. However, no significant association was found for the rs1695 polymorphism under all assessed modes of inheritance. Findings of the present meta-analysis demonstrated that GSTM1 and GSTT1 null genotypes may serve as predisposing factors for essential hypertension. Further studies are warranted to validate this association, and also to explore if these null genotypes are in linkage with other hypertension susceptibility polymorphisms.
KeywordsCardiovascular disease Blood pressure Systematic review Pooled analysis Glutathione
Compliance with Ethics Guidelines
Conflict of Interest
Saeid Eslami and Amirhossein Sahebkar declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 5.World Health Organization. Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization; 2002. World Health Report. 2002.Google Scholar
- 6.Pessina AC. Hypertension and atherosclerosis. Cardiologia. 1999;44:S259–63.Google Scholar
- 7.Kobayashi M, Uesugi S. The role of hypertension as a risk factor of atherosclerosis. Rinsho byori. Jpn J Clin Pathol. 1995;43:104–10.Google Scholar
- 12.Richard CS, Peter WJ, Anthony AF. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett. 2000;112–113:357–63.Google Scholar
- 16.Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272:10004–12.PubMedCrossRefGoogle Scholar
- 22.Wang R, Wang Y, Wang J, Yang K. Association of glutathione S-transferase T1 and M1 gene polymorphisms with ischemic stroke risk in the Chinese Han population. Neural Regen Res. 2012;7:1420–7.Google Scholar
- 27.•Bessa SS, Ali EMM, Hamdy SM. The role of glutathione S- transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in egyptian patients with essential hypertension. Eur J Intern Med. 2009;20:625–30. This is the largest study indicating the significant association between both GSTM1 and GSTT1 null genotypes and risk of essential hypertension.PubMedCrossRefGoogle Scholar